Pediatrician warns about energy drink risks for teens

Johns Hopkins researchers say nearly a third of teens ages 12 to 17 regularly drink energy drinks, raising concerns about caffeine's effects on young people.

Microsoft develops AI tool that can diagnose 'sequentially' like a doctor

Microsoft researchers say an AI tool that diagnoses patients step by step, as doctors do, was ​more than twice as accurate as general physicians at solving complex medical cases, according to a study published on Thursday in Science.

Vor Bio says its experimental drug slowed loss of kidney function in late-stage study

US biotech company Vor Bio said on Thursday ​its experimental kidney disease drug slowed the loss of kidney function and reduced the risk of ‌disease progression in a late-stage study.

The connection between having in-person friends and problematic social media use

Do you spend too much time on social media? Is it interfering with other parts of your life? New research suggests what could be driving your behavior.

Gilead to buy PepStar's inflammation drug program in $1.28 billion deal

Gilead Sciences said on Thursday it will ​acquire PepStar Therapeutics' oral inflammation drug program, including an experimental bowel disease treatment, for $1.275 ‌billion in cash upfront.

Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat

Moderna's shares sank over 25% on Thursday as late-stage trial data for its ​personalized melanoma vaccine, developed with Merck, triggered what analysts called a "sell-the-news" reaction after a months-long stock surge.

Taco Bell sticks with Pepsi as sister chain switches to Coke

KFC dumped PepsiCo last week, but its sister chain Taco Bell announced Thursday it's keeping the Mountain Dew Baja Blast maker on for another decade.

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

Moderna and Merck said on Thursday that their mRNA cancer vaccine when combined with Merck's widely used immunotherapy cut the risk ​of melanoma death or recurrence by 42% in a large trial, potentially paving the way for a new era of personalized treatment.

Explainer-What is Shamonda virus and what are the risks to humans and animals?

France has reported the first known human case of Shamonda virus in a patient who ​died, raising questions about the risks posed by a livestock virus that has reached Europe this year decades after first being detected in Nigeria.

Airbnb rule change frees guests from chores involving 'significant effort'

Airbnb has revised its rules to reduce the tasks a host can expect a guest to perform at the end of their stay — and washing dishes has been wiped from the to-do list.

AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination

AbbVie said on Thursday its experimental drug significantly reduced inflammatory lumps ​and abscesses in patients with a chronic skin disease, meeting the main goal of a late-stage study.

Laboratory operator Quest reports cyber breach affecting patient records

Quest Diagnostics on Thursday said it ​learned of unauthorized access to its Quanum LSM system, which some clients use ‌to place test orders, receive and look up results.

France reports first human case of livestock virus Shamonda after patient dies

France reported the first human case of the Shamonda virus usually found in ​livestock on Thursday in a hospital patient who died, though authorities said there was no risk to the general population.

Galderma lifts outlook for second quarter in a row after sales jump

Swiss skincare company Galderma raised its full-year sales ​guidance on Thursday for the second time in two quarters after strong demand for its therapeutic ‌dermatology products drove robust growth in the first nine months of the ⁠year.